Dr. Meyerhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana-Farber Cancer Inst
Boston, MA 02215Phone+1 617-632-6855Fax+1 617-632-5370- Is this information wrong?
Summary
- Dr. Jeffrey Meyerhardt is an oncologist in Boston, MA and is affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 20 years. He specializes in gastrointestinal oncology.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2002
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
- Yale School of MedicineClass of 1997
Certifications & Licensure
- MA State Medical License 1999 - 2024
- RI State Medical License 2020 - 2020
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer Start of enrollment: 2005 Jan 01
- Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer Start of enrollment: 2002 Jul 01
- Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Start of enrollment: 2003 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Ultra-processed food consumption and mortality among patients with stages I-III colorectal cancer: a prospective cohort study.Dong Hang, Mengxi Du, Lu Wang, Kai Wang, Zhe Fang, Neha Khandpur, Sinara Laurini Rossato, Eurídice Martínez Steele, Andrew T Chan, Frank B Hu, Jeffrey A Meyerhardt, Da...> ;Eclinicalmedicine. 2024 May 1
- RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Eliza...> ;Clinical Cancer Research. 2024 Apr 15
- Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven Alberts, Aimery de Gramont, Jeffrey A Meyerhardt, Thomas George, ...> ;Journal of Clinical Oncology. 2024 Mar 28
- Join now to see all
Journal Articles
- Aspirin Use and Risk of Colorectal Cancer Among Older AdultsLong H Nguyen, Kimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, JAMA Oncology
- Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 TrialKimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open
- Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal CancerI-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology
Lectures
- Lessons From IDEA: Duration in Stage II and III Colon CancerASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Other
- Infusion reactions to therapeutic monoclonal antibodies used for cancer therapyMeyerhardt JA, LaCasce AS, Burstein H, Castells MC
http://www.uptodate.com/contents/infusion-reactions-to-therapeutic-monoclonal-antibodies-used-for-ca
UpToDate, Wolters Kluwer Health - 2013-03-22 - The roles of diet, physical activity, and body weight in cancer survivorshipMeyerhardt JA, Ligibel J
http://www.uptodate.com/contents/the-roles-of-diet-physical-activity-and-body-weight-in-cancer-survi
UpToDate, Wolters Kluwer Health - 2013-04-09 - Cancer of the appendix and pseudomyxoma peritoneiMeyerhardt JA, Swanson R
http://www.uptodate.com/contents/cancer-of-the-appendix-and-pseudomyxoma-peritonei
UpToDate, Wolters Kluwer Health - 2013-03-22
Authored Content
- Vitamin D Status After Colorectal Cancer Diagnosis and Patient Survival According to Immune Response to TumourOctober 2018
Press Mentions
- Do You Really Need That Colonoscopy?October 24th, 2022
- Panitumumab Bests Bevacizumab in Metastatic Left-Sided Colon Cancer That Is RAS Wild-TypeJune 5th, 2022
- Sugary Drinks May Double Bowel Cancer Risk in Women Under 50May 9th, 2021
- Join now to see all
Grant Support
- Exercise And Metformin To Impact Hyperinsulinemia In Colorectal Cancer SurvivorsNational Cancer Institute2011
- The Influence Of Diet And Lifestyle On Patients With Advanced Colorectal CancerNational Cancer Institute2010–2011
- The Role Of Pi3-Kinase Signaling Pathway In Defining Sensitivity And ResistanceNational Cancer Institute2007–2011
- Predictors Of Outcome In Colorectal CancerNational Cancer Institute2003–2007
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: